SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000946644-15-000071
Filing Date
2015-11-23
Accepted
2015-11-23 16:31:31
Documents
5
Period of Report
2015-11-23
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kreportcarterxequelswai.htm 8-K 29213
2 EXHIBIT 10.1 exhibit101willianacarter.htm EX-10.1 6730
3 EXHIBIT 10.2 exhibit102thomaskequels.htm EX-10.2 7018
4 carterwaiver112315fin_image1.gif GRAPHIC 52549
5 equelswaiver112315fin_image1.gif GRAPHIC 52549
  Complete submission text file 0000946644-15-000071.txt   189171
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 151250018
SIC: 2836 Biological Products, (No Diagnostic Substances)